Ontology highlight
ABSTRACT: Importance
Understanding adverse effects of contemporary treatment approaches for men with favorable-risk and unfavorable-risk localized prostate cancer could inform treatment selection.Objective
To compare functional outcomes associated with prostate cancer treatments over 5 years after treatment.Design, setting, and participants
Prospective, population-based cohort study of 1386 men with favorable-risk (clinical stage cT1 to cT2bN0M0, prostate-specific antigen [PSA] ≤20 ng/mL, and Grade Group 1-2) prostate cancer and 619 men with unfavorable-risk (clinical stage cT2cN0M0, PSA of 20-50 ng/mL, or Grade Group 3-5) prostate cancer diagnosed in 2011 through 2012, accrued from 5 Surveillance, Epidemiology and End Results Program sites and a US prostate cancer registry,
SUBMITTER: Hoffman KE
PROVIDER: S-EPMC6990712 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature